Charles Everhardt - Net Worth and Insider Trading

Charles Everhardt Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Charles Everhardt owns 1 companies in total, including Innovative MedTech Inc (IMTH) .

Click here to see the complete history of Charles Everhardt’s form 4 insider trades.

Insider Ownership Summary of Charles Everhardt

Ticker Comapny Transaction Date Type of Owner
IMTH Innovative MedTech Inc 2021-03-25 director & 10 percent owner & other: Chairman of the Board

Charles Everhardt Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Charles Everhardt Ownership Network

Ownership Network List of Charles Everhardt

No Data

Ownership Network Relation of Charles Everhardt

Insider Network Chart

Charles Everhardt Owned Company Details

What does Innovative MedTech Inc do?

Who are the key executives at Innovative MedTech Inc?

Charles Everhardt is the director & 10 percent owner & other: Chairman of the Board of Innovative MedTech Inc. Other key executives at Innovative MedTech Inc include Chief Executive Officer Merle Griff , 10 percent owner Eddie Dovner , and 10 percent owner Arthur Friedman .

Innovative MedTech Inc (IMTH) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Innovative MedTech Inc (IMTH) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Innovative MedTech Inc (IMTH) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Innovative MedTech Inc (IMTH)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Innovative MedTech Inc Insider Transactions

No Available Data

Charles Everhardt Mailing Address

Above is the net worth, insider trading, and ownership report for Charles Everhardt. You might contact Charles Everhardt via mailing address: 2310 York St, Ste 200, Blue Island Il 60406.

Discussions on Charles Everhardt

No discussions yet.